Diseases, Conditions, Syndromes

Two potential therapies for preventing myofibroblast differentiation

Multiple types of cells are needed for patients to recover from surgery or to restore life to tissues that have lost circulation. University of Georgia researchers have identified how the cells involved in the final stage ...

Oncology & Cancer

Block estrogen to treat lung disease

The strongest epidemiological risk factor for many forms of pulmonary arterial hypertension (PAH) is female gender. Increased estrogen makes females three times more likely to develop PAH, a chronic disease that eventually ...

Medications

Adempas approved to treat pulmonary hypertension

(HealthDay)—Adempas (riociguat) has been approved by the U.S. Food and Drug Administration to treat two types of pulmonary hypertension, characterized by high blood pressure in the arteries of the lungs.

page 15 from 24